The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Pectasides, D., Pectasides E., Papaxoinis G., Andreadis C., Papatsibas G., Fountzilas G., et al. (2009).  Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.. Gynecol Oncol. 115(1), 97-101.
Pectasides, E., Rampias T., Sasaki C., Perisanidis C., Kouloulias V., Burtness B., et al. (2014).  Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).. PLoS One. 9(4), e94273.
Pectasides, D., Papaxoinis G., Fountzilas G., Aravantinos G., Bamias A., Pavlidis N., et al. (2009).  Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).. Anticancer Res. 29(2), 745-51.
Pectasides, D., Dafni U., Bafaloukos D., Skarlos D., Polyzos A., Tsoutsos D., et al. (2009).  Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.. J Clin Oncol. 27(6), 939-44.
Pectasides, E., Chatzidakis I., Kotoula V., Koliou G-A., Papadopoulou K., Giannoulatou E., et al. (2020).  Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.. Cancer Genomics Proteomics. 17(3), 277-290.
Pectasides, E., Rampias T., Kountourakis P., Sasaki C., Kowalski D., Fountzilas G., et al. (2011).  Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.. Clin Cancer Res. 17(9), 2947-54.
Pectasides, D., Papaxoinis G., Nikolaou M., Valavanis C., Aravantinos G., Fountzilas G., et al. (2009).  Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.. Anticancer Res. 29(2), 737-44.
Pectasides, D., Papaxoinis G., Kotoula V., Fountzilas H., Korantzis I., Koutras A., et al. (2012).  Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.. Oncol Rep. 27(1), 216-24.
Pectasides, E., Egloff A-M., Sasaki C., Kountourakis P., Burtness B., Fountzilas G., et al. (2010).  Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis.. Clin Cancer Res. 16(8), 2427-34.
Pectasides, D., Karavasilis V., Papaxoinis G., Gourgioti G., Makatsoris T., Raptou G., et al. (2015).  Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or. BMC Cancer. 15, 384.
Pectasides, D., Kotoula V., Papaxoinis G., Alexopoulou Z., Dervenis C., Samantas E., et al. (2016).  Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.. Anticancer Res. 36(12), 6347-6356.
Pectasides, D., Papaxoinis G., Kalogeras K. T., Eleftheraki A. G., Xanthakis I., Makatsoris T., et al. (2012).  XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.. BMC Cancer. 12, 271.
Pectasides, D., Fountzilas G., Papaxoinis G., Pectasides E., Xiros N., Sykiotis C., et al. (2009).  Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.. Int J Gynecol Cancer. 19(4), 777-81.
Pefkianaki, M., Androudi S., Praidou A., Sourlas V., Zakynthinos E., Brazitikos P., et al. (2011).  Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis.. J Ophthalmic Inflamm Infect. 1(4), 141-5.
Pegg, T. J., Maunsell Z., Karamitsos T. D., Taylor R. P., James T., Francis J. M., et al. (2011).  Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI.. Heart. 97(10), 810-6.
Pękala, P. A., Henry B. Michael, Pękala J. R., Frączek P. A., Taterra D., Natsis K., et al. (2017).  The pterygoalar bar: A meta-analysis of its prevalence, morphology and morphometry.. J Craniomaxillofac Surg. 45(9), 1535-1541.
Pellios, S., Kenanidis E., Potoupnis M., Tsiridis E., Sayegh F. E., Kirkos J., et al. (2016).  Curve progression 25 years after bracing for adolescent idiopathic scoliosis: long term comparative results between two matched groups of 18 versus 23 hours daily bracing.. Scoliosis Spinal Disord. 11, 3.
Pells, S., Koutsouraki E., Morfopoulou S., Valencia-Cadavid S., Tomlinson S. R., Kalathur R., et al. (2015).  Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State.. PLoS One. 10(7), e0131102.
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Pentheroudakis, G., Pavlidis N., Fountzilas G., Krikelis D., Goussia A., Stoyianni A., et al. (2013).  Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.. Mol Cancer. 12, 57.
Pentheroudakis, G., Angouridakis N., Wirtz R., Nikolaou A., Kalogeras K. T., Pavlidis N., et al. (2009).  Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.. J Oncol. 2009, 854127.
Pentheroudakis, G., Kotoula V., Fountzilas E., Kouvatseas G., Basdanis G., Xanthakis I., et al. (2014).  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).. BMC Cancer. 14, 111.
Pentheroudakis, G., Kotoula V., Kouvatseas G., Charalambous E., Dionysopoulos D., Zagouri F., et al. (2014).  Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.. Clin Breast Cancer. 14(5), 330-8.
Pentheroudakis, G., Kotteas E. A., Kotoula V., Papadopoulou K., Charalambous E., Cervantes A., et al. (2014).  Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group.. Clin Exp Metastasis. 31(7), 761-9.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.